ES2132651T3 - Derivados amidicos de la vitamina d. - Google Patents

Derivados amidicos de la vitamina d.

Info

Publication number
ES2132651T3
ES2132651T3 ES95912345T ES95912345T ES2132651T3 ES 2132651 T3 ES2132651 T3 ES 2132651T3 ES 95912345 T ES95912345 T ES 95912345T ES 95912345 T ES95912345 T ES 95912345T ES 2132651 T3 ES2132651 T3 ES 2132651T3
Authority
ES
Spain
Prior art keywords
pct
group
sec
alpha
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95912345T
Other languages
English (en)
Inventor
Robert Henry Hesse
Sundara Katugam Srinivas Setty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Medicine and Chemistry Inc
Original Assignee
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Medicine and Chemistry Inc filed Critical Research Institute for Medicine and Chemistry Inc
Application granted granted Critical
Publication of ES2132651T3 publication Critical patent/ES2132651T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPUESTO DE LA FORMULA GENERAL (I) DONDE R 1 Y R SUP,2}, LOS CUALES PUEDEN SER IGUALES O DIFERENTES, CADA UNO REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALIFATICO, CICLOALIFATICO, ARALIFATICO O ARILO O JUNTO AL ATOMO DE NITROGENO AL QUE ESTAN UNIDOS FORMAN UN GRUPO HETEROCICLICO; R{SUP,3} REPRESENTA UN GRUPO METILO QUE TIENE UNA CONFIGURACION {AL}- O {BE}-; UNO DE R{SUP,A} Y R{SUP,B} REPRESENTA UN GRUPO HIDROXI O UN GRUPO HIDROXI PROTEGIDO Y EL OTRO REPRESENTA UN ATOMO DE HIDROGENO; Y REPRESENTA UN ENLACE DE VALENCIA O UN GRUPO ALQUILENO QUE CONTIENE MAS DE 3 ATOMOS DE CARBONO; Y A= REPRESENTA UNA ESTRUCTURA DE CICLOHEXILIDENO CARACTERISTICO DE UN A-ANILLO DE UNA VITAMINA D 1{AL}-HIDROXILADA O ANALOGA DE ELLA.COMPUESTOS ACTIVOS DE LA INVENCION MUESTRAN SEPARACION DE LA MODULACION CELULAR Y ACTIVIDADES CALCEMICAS JUNTO CON UNA DURACION AUMENTADA DE LA ACTIVIDAD.
ES95912345T 1994-03-23 1995-03-23 Derivados amidicos de la vitamina d. Expired - Lifetime ES2132651T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9405715A GB9405715D0 (en) 1994-03-23 1994-03-23 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2132651T3 true ES2132651T3 (es) 1999-08-16

Family

ID=10752346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95912345T Expired - Lifetime ES2132651T3 (es) 1994-03-23 1995-03-23 Derivados amidicos de la vitamina d.

Country Status (21)

Country Link
US (1) US5811562A (es)
EP (1) EP0751932B1 (es)
JP (1) JP3790544B2 (es)
KR (1) KR100361556B1 (es)
CN (1) CN1073557C (es)
AT (1) ATE181063T1 (es)
AU (1) AU685249B2 (es)
CA (1) CA2185813A1 (es)
CZ (1) CZ290304B6 (es)
DE (1) DE69510189T2 (es)
DK (1) DK0751932T3 (es)
ES (1) ES2132651T3 (es)
FI (1) FI112359B (es)
GB (1) GB9405715D0 (es)
GR (1) GR3031084T3 (es)
HU (1) HUT75520A (es)
IL (1) IL113113A (es)
NO (1) NO309188B1 (es)
NZ (1) NZ282453A (es)
WO (1) WO1995025718A1 (es)
ZA (1) ZA952377B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6043385A (en) * 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
AU2005201074B2 (en) * 1999-08-17 2007-10-18 Battelle Memorial Institute A Chemical reactor and method for gas phase reactant catalytic reactions
EP1206316B1 (en) * 1999-08-17 2005-06-29 Battelle Memorial Institute Chemical reactor and method for catalytic gas phase reactions
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
CA2424555A1 (en) 2000-10-02 2002-04-11 Emory University Triptolide analogs for the treatment of autoimmune and inflammatory disorders
CA2981549A1 (en) 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
SG10201404883YA (en) 2009-08-14 2014-10-30 Berg Llc Vitamin d3 and analogs thereof for treating alopecia
AU2014274099A1 (en) 2013-05-29 2015-12-24 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin D

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288031B6 (cs) * 1991-11-07 2001-04-11 Research Institute For Medicine And Chemistry Amidové deriváty vitaminu D, způsob výroby a farmaceutické prostředky s jejich obsahem
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
DE4234382A1 (de) * 1992-10-06 1994-04-07 Schering Ag 25-Carbonsäure-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
GB9309422D0 (en) * 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds

Also Published As

Publication number Publication date
CA2185813A1 (en) 1995-09-28
JPH09510472A (ja) 1997-10-21
DE69510189T2 (de) 1999-11-11
DE69510189D1 (de) 1999-07-15
HU9602572D0 (en) 1996-11-28
KR100361556B1 (ko) 2003-02-17
AU1956095A (en) 1995-10-09
FI963754A0 (fi) 1996-09-20
US5811562A (en) 1998-09-22
NZ282453A (en) 1997-04-24
DK0751932T3 (da) 1999-11-15
ATE181063T1 (de) 1999-06-15
JP3790544B2 (ja) 2006-06-28
CZ290304B6 (cs) 2002-07-17
WO1995025718A1 (en) 1995-09-28
ZA952377B (en) 1996-02-07
KR970701692A (ko) 1997-04-12
NO963949L (no) 1996-11-22
GR3031084T3 (en) 1999-12-31
IL113113A (en) 2001-03-19
CN1149288A (zh) 1997-05-07
EP0751932B1 (en) 1999-06-09
NO963949D0 (no) 1996-09-20
NO309188B1 (no) 2000-12-27
IL113113A0 (en) 1995-06-29
CZ266096A3 (en) 1997-06-11
CN1073557C (zh) 2001-10-24
EP0751932A1 (en) 1997-01-08
FI112359B (fi) 2003-11-28
FI963754A (fi) 1996-09-20
HUT75520A (en) 1997-05-28
AU685249B2 (en) 1998-01-15
GB9405715D0 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DE69412476D1 (de) Vitamin-d-amid-derivate
DE69414115D1 (de) Vitamin d analoge
DE69125185D1 (de) Einfluss von n,n,n-trimethylsphingosin auf die aktivität der protein-c-kinase, melanomzellwachstum in vitro, metastatisches potential in vivo und humane blutblättchenaggregation
TR199701531T1 (xx) Ektoparazit �ld�r�c� bile�imler.
ES2132651T3 (es) Derivados amidicos de la vitamina d.
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
ES465340A1 (es) Procedimiento para la obtencion de derivados de amino-azu- car.
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
ES2149957T3 (es) Derivados aminicos y amidicos de la vitamina d.
EP1061070A4 (en) 24-hydroxy vitamin D derivatives
HUT71523A (en) Gestagenically active 19,11-bridged 4-estrenes and pharmaceutical compositions containing the same
ATE155791T1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
GB9523637D0 (en) Synthesis of carboxylic acid derivatives
DE59406568D1 (de) Cephalostatin-analoga und ihre verwendung als antitumormittel
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 751932

Country of ref document: ES